|
|||||
|
|
Real-world evaluation of TNF-inhibitor utilization in rheumatoid arthritis |
|
| Authors: | J Harnett D Wiederkehr R Gerber D Gruben A Koenig J Bourret |
| Institution: | 1. Pfizer Inc, New York, NY, USAjames.harnett@pfizer.com;3. Pfizer Inc, New York, NY, USA;4. Pfizer Inc, Groton, CT, USA;5. Pfizer Inc, Collegeville, PA, USA |
| Abstract: | |
| Keywords: | TNF inhibitor Treatment patterns Cost analysis Real-world experience |